Enteric Coated Rabeprazole Sodium & Sustained Release Levosulpiride Capsules
A combination medication for the treatment of GERD, acid reflux, and functional dyspepsia. Rabeprazole (20 mg) reduces stomach acid, while Levosulpiride (75 mg) enhances gastrointestinal motility, providing dual relief from acid-related and motility disorders. The enteric coating ensures effective acid suppression, and the sustained release formulation offers prolonged symptom control. Use as prescribed by a physician.
